Home > Insider Trading > Filing (0001213900-20-045807)

Filing Details

Accession Number:: 0001213900-20-045807
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-12-31 17:24:00
Reporting Period:: 2020-12-29

Accepted Time:: 2020-12-31 17:24:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1218683	Wize Pharma Inc.	WIZP	Pharmaceutical Preparations (2834)	880445167

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1720898	Noam Danenberg	C/O Wize Pharma, Inc. 24 Hanagar Street Hod Hasharon L3 4527708	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-12-29	125,000	$0.00	1,077,681	No	4	X	Direct
Common Stock	Disposition	2020-12-29	962	$0.00	1,076,719	No	4	S	Direct
Common Stock	Acquisiton	2020-12-29	1,505,162	$0.00	2,581,881	No	4	X	Indirect	See Footnote
Common Stock	Disposition	2020-12-29	12,543	$0.00	2,569,338	No	4	S	Indirect	See Footnote
Common Stock	Acquisiton	2020-12-29	173,607	$0.00	2,742,945	No	4	X	Indirect	See Footnote
Common Stock	Disposition	2020-12-29	1,447	$0.00	2,741,498	No	4	S	Indirect	See Footnote
Common Stock	Acquisiton	2020-12-29	63,236	$0.00	2,804,734	No	4	X	Indirect	See Footnote
Common Stock	Disposition	2020-12-29	507	$0.00	2,804,227	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	X	Direct
No	4	S	Direct
No	4	X	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	X	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	X	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant (right to buy)	Disposition	2020-12-29	125,000	$0.00	125,000	$0.16
Common Stock	Warrant (right to buy)	Disposition	2020-12-29	1,505,162	$0.00	1,505,162	$0.27
Common Stock	Warrant (right to buy)	Disposition	2020-12-29	173,607	$0.00	173,607	$0.16
Common Stock	Future Investment Rights	Disposition	2020-12-29	63,236	$0.00	63,236	$0.27

Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2019-04-21	2023-10-23	No	4	X	Direct
	2024-12-12	No	4	X	Indirect
2019-05-31	2021-05-30	No	4	X	Indirect
2019-12-13	2024-12-12	No	4	X	Indirect

Footnotes

On December 23, 2020 the registrant has voluntary reduced the exercise price of warrants to $0.001. The reporting person exercised a warrant to purchase shares of the registrant's common stock for the reduced exercise price.
On December 29, 2020 the reporting person exercised a warrant to purchase 125,000 shares of the registrant's common stock for $0.16 a share. The reporting person paid the exercise price on a cashless basis, resulting in the registrant withholding of 962 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 124,038 shares.
On December 29, 2020 the reporting person exercised a warrant to purchase 1,505,162 shares of the registrant's common stock for $0.27 a share. The reporting person paid the exercise price on a cashless basis, resulting in the registrant withholding of 12,543 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 1,492,619 shares.
On December 29, 2020 the reporting person exercised a warrant to purchase 173,607 shares of the registrant's common stock for $0.16 a share. The reporting person paid the exercise price on a cashless basis, resulting in the registrant withholding of 1,447 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 172,160 shares.
On December 29, 2020 the reporting person exercised a warrant to purchase 63,236 shares of the registrant's common stock for $0.27 a share. The reporting person paid the exercise price on a cashless basis, resulting in the registrant withholding of 507 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 62,729 shares.
Securities held by Mobigo Inc.
Exercisable five days following the public announcement of positive clinical data results for LO2A.